Class II · ModerateActive recall
SEMAGLUTIDE 5mg/2mL (2.5mg/mL)
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot #: ProRx052424, BUD 11/23/2024 ProRx060724, BUD 12/06/2024 ProRx061124, BUD 12/10/2024 ProRx061924, BUD 12/18/2024
Where it was soldNationwide in the USA
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Lack of Assurance of Sterility
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | ProRx LLC |
| NDC | 84139-225-01 |
Show the full FDA record
| Full product label | SEMAGLUTIDE 5mg/2mL (2.5mg/mL), Rx Only 2 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-01 |
| Recalling firm | ProRx LLC |
| Distribution | Nationwide in the USA |
| Quantity | 8,396 vials |
| Recall initiated | 2024-08-22 |
| Report date | 2024-09-11 |
| Recall completed | — |
| Recall number | D-0652-2024 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Exton PA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.